Patents by Inventor Adys González Palomo

Adys González Palomo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INORGANIC NANOPARTICLE-BASED VACCINE COMPOSITIONS FOR CANCER TREATMENT
    Publication number: 20230226163
    Abstract: The present invention is related to biotechnology, particularly to the field of human health. It provides new vaccine compositions that comprise as active principle a system that contains the recombinant human EGF, or peptides thereof, and a carrier protein or peptide, bound to a nucleus constituted by inorganic nanoparticles, with nanometric or submicrometric scale dimensions. These vaccine compositions are useful for the chronic treatment of cancer and have as advantages that their administration does not result in the appearance of adverse effects at the injection site and that they do not accumulate in the body.
    Type: Application
    Filed: May 31, 2021
    Publication date: July 20, 2023
    Inventors: Gustavo González Ruiz, David Alejandro González Martínez, Fernando Bordallo León, Belinda Sánchez Ramírez, Kalet León Monzón, Yerandy Echeverría Luna, Maria del Carmen Luzardo Lorenzo, Mabel Cruz Rodríguez, Adys González Palomo, Julio Felipe Santo Tomás Pompa, Judey Aymed García Artalejo, Elaine Ruiz Castro, Lien López Matilla
  • Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)
    Patent number: 9790279
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: October 17, 2017
    Assignee: CENTRO DE IMMUNOLOGIA MOLECULAR
    Inventors: Adys González Palomo, Adriana Carr Perez, Kalet León Monzón, Rancés Blanco Santana, María del Carmen Barroso Alvarez, Amparo Emilia Macías Abraham, José Enrique Montero Casimiro
  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND GM3 N-GLYCOLYL GANGLIOSIDE (NeuGcGM3)
    Publication number: 20140363494
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
    Type: Application
    Filed: December 4, 2012
    Publication date: December 11, 2014
    Inventors: Adys González Palomo, Adriana Carr Perez, Kalet León Monzón, Rancés Blanco Santana, María del Carmen Barroso Alvarez, Amparo Emilia Macías Abraham, José Enrique Montero Casimiro